中文名称: 苄丝肼 盐酸盐 促销
英文名称: Benserazide hydrochloride
CAS No: 14919-77-8
分子式: C10H15N3O5.HCl
分子量: 293.7
EINEC: 238-991-9
B10016 苄丝肼 盐酸盐 ≥98% (psaitong)
熔点:
146-148°C
包装规格:
1g 5g in glass bottle
溶解性:
溶于水(10mg/mg)、DMSO和甲醇,不溶于乙醇和丙酮.
产品描述:

基本信息

产品编号:

B10016

产品名称:

Benserazide hydrochloride

CAS:

14919-77-8

 

储存条件

粉末

室温

四年

 

 

分子式:

C10H15N3O5.HCl

溶于液体

-80℃

两年

分子量

293.70

-20℃

一个月

化学名: 

2'-(2,3,4-Trihydroxybenzyl)-DL-serinohydrazide monohydrochloride

Solubility (25°C):

 

体外:

 

DMSO

58mg/mL (197.48mM)

Ethanol

1mg/mL warmed with 50ºC water bath (3.4mM)

Water

58mg/mL (197.48mM)

体内(现配现用):

1.请依序添加每种溶剂:PBS

Solubility: 100mg/mL (340.48mM); Clear solution; Need ultrasonic

2.请依序添加每种溶剂:10% DMSO40% PEG3005% Tween-8045% saline

Solubility: ≥ 2.08mg/mL (7.08mM); Clear solution

此⽅案可获得 ≥ 2.08mg/mL (7.08mM,饱和度未知) 的澄清溶液。 以 1mL ⼯作液为例,取 100μL 20.8mg/mL 的澄清 DMSO 储备液加到 400μL PEG300 中,混合均匀;向上述体系中加⼊ 50μL Tween-80,混合均匀;然后继续加⼊ 450μL ⽣理盐⽔定容⾄ 1mL

3.请依序添加每种溶剂:10% DMSO90% (20% SBE-β-CD in saline)

Solubility: ≥ 2.08mg/mL (7.08mM); Clear solution

此⽅案可获得 ≥ 2.08mg/mL (7.08mM,饱和度未知) 的澄清溶液。 以 1mL ⼯作液为例,取 100μL 20.8mg/mL 的澄清 DMSO 储备液加到 900μL 20% 的 SBE-β-CD ⽣理盐⽔⽔溶液中,混合均匀。

4.请依序添加每种溶剂:10% DMSO90% corn oil

Solubility: ≥ 2.08mg/mL (7.08mM); Clear solution

此⽅案可获得 ≥ 2.08mg/mL (7.08mM,饱和度未知) 的澄清溶液,此⽅案不适⽤于实验周期在半个⽉以上的实验。 以 1mL ⼯作液为例,取 100μL 20.8mg/mL 的澄清 DMSO 储备液加到 900μL ⽟⽶油中,混合均匀。

1mg/ml表示微溶或不溶。

普西唐提供的所有化合物浓度为内部测试所得,实际溶液度可能与公布值有所偏差,属于正常的批间细微差异现象。

请根据产品在不同溶剂中的溶解度选择合适的溶剂配制储备液;⼀旦配成溶液,请分装保存,避免反复冻融造成的产品失效。

 

制备储备液

 

浓度

 

溶液体积

质量

 

1mg

 

5mg

 

10mg

1mM

3.4048mL

17.0242mL

34.0483mL

5mM

0.6810mL

3.4048mL

6.8097mL

10mM

0.3405mL

1.7024mL

3.4048mL

50mM

0.0681mL

0.3405mL

0.6810mL

 

生物活性

产品描述

多巴脱羧酶抑制剂,

靶点

aromatic-L-amino-acid decarboxylase 

DOPA decarboxylase 

体外研究

Benserazide hydrochloride (BH) and Levodopa (LD) individually and in combination (Benserazide hydrochloride + LD) (25μM; 0 hour, 12 hours, 24 hours and 168 hours; SH-SY5Y) treatment inhibit protein aggregation and have the ability to minimise the amyloid-induced cytotoxicity in human neuroblastoma cell line. Benserazide hydrochloride and LD both can act as efficient inhibitors of the formation of cytotoxic HSA aggregates, and the inhibitory effects are more pronounced when both of these drugs are added simultaneously

Cell Viability Assay

Cell Line:

SH-SY5Y cells

Concentration:

25μM

Incubation Time:

0 hour, 12 hours, 24 hours and 168 hours

Result:

Enhanced cell viability, and inhibited the formation of cytotoxic human serum albumin (HSA) aggregates.

体内研究

Benserazide (5-50mg/kg; intraperitoneal injection; male Wistar rats) treatment of 6-OHDA-lesioned rats increases exogenous L-DOPA-derived extracellular DA levels, the time to reach the peak DA levels are significantly prolong by Benserazide dosedependently. The AADC activity in the denervates striatal tissues shows a significant decrease by 10mg/kg and 50mg/kg Benserazide. Benserazide reduces the central AADC activity in the striatum of rats with nigrostriatal denervation, which leads to changes in the metabolism of exogenous L-DOPA

Animal Model:

Male Wistar rats with 6-hydroxydopamine (6-OHDA) (8 Ag/4 Al)

Dosage:

5mg/kg, 10mg/kg or 50mg/kg (Pharmacokinetic study)

Administration:

Intraperitoneal injection

Result:

Increased in exogenous L-DOPA-derived extracellular DA levels, the time to reach the peak DA levels were significantly prolonged in a dose-dependent fashion. The AADC activity in the denervated striatal tissues showed a significant decreased by 10mg/kg and 50mg/kg.

保存条件:
室温 避光 干燥
UN码:
HazardClass:
危害声明:
安全说明:
搜索质检报告(COA)
参考文献 & 客户发表文献

本计算器可帮助您计算出特定溶液中溶质的质量、溶液浓度和体积之间的关系,公式为:
质量 (g) = 浓度 (mol/L) x 体积 (L) x 分子量 (g/mol)

摩尔浓度计算公式

  • =
    *
    *
    *选择对应的单位 *空出希望得到的变量,填写另外两个变量

用本工具协助配置特定浓度的溶液,使用的计算公式为:
开始浓度 x 开始体积 = 最终浓度 x 最终体积

稀释公式

稀释公式一般简略地表示为:C1V1 = C2V2 ( 输入 输出 )

  • * = *

连续稀释计算器方程

  • 连续稀释

  • 初始浓度:
  • 稀释倍数:
  • 计算结果

  • C1=C0/X C1: LOG(C1):
    C2=C1/X C2: LOG(C2):
    C3=C2/X C3: LOG(C3):
    C4=C3/X C4: LOG(C4):
    C5=C4/X C5: LOG(C5):
    C6=C5/X C6: LOG(C6):
    C7=C6/X C7: LOG(C7):
    C8=C7/X C8: LOG(C8):